Page 1 | Search Results | Cancer Epidemiology, Biomarkers & Prevention

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Sensitivity Measures in Studies of Cancer Early Detection Biomarkers

Yibai Zhao, Roman Gulati, Jane Lange, Antonio Olivas-Martinez, Sana Raoof, Yingye Zheng, Ziding Feng, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev OF1–OF8.

https://doi.org/10.1158/1055-9965.EPI-24-1849

Published: 30 April 2025

View articletitled, Sensitivity Measures in Studies of Cancer Early Detection Biomarkers

Includes: Supplementary data

Journal Articles

Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study

Mengmeng Ji, Yi-Hsuan Shih, John H. Huber, Mei Wang, Eric J. Feuer, Ruth Etzioni, Shi-Yi Wang, Su-Hsin Chang

Cancer Epidemiol Biomarkers Prev (2024) 33 (12): 1690–1697.

https://doi.org/10.1158/1055-9965.EPI-24-0490

Published: 02 December 2024

View articletitled, Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study

Includes: Supplementary data

Journal Articles

Abstract B084: Multi-Stakeholder Engagement to Create Equity in Prostate Cancer Outcomes through Identifying Community Priorities in Early Detection Research

Cancer Epidemiol Biomarkers Prev (2024) 33 (9_Supplement): B084.

https://doi.org/10.1158/1538-7755.DISP24-B084

Published: 21 September 2024

View articletitled, Abstract B084: Multi-Stakeholder Engagement to Create Equity in Prostate Cancer Outcomes through Identifying Community Priorities in Early Detection Research

Journal Articles

Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Jane M. Lange, Kemal Caglar Gogebakan, Roman Gulati, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2024) 33 (6): 830–837.

https://doi.org/10.1158/1055-9965.EPI-23-1470

Published: 03 June 2024

View articletitled, Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Includes: Supplementary data

Journal Articles

Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment

Noah Hammarlund, Sarah K. Holt, Anirban Basu, Ruth Etzioni, Danté Morehead, Jenney R. Lee, Erika M. Wolff, John L. Gore, Yaw A. Nyame

Cancer Epidemiol Biomarkers Prev (2024) 33 (3): 435–441.

https://doi.org/10.1158/1055-9965.EPI-23-0892

Published: 01 March 2024

View articletitled, Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment

Includes: Supplementary data

Journal Articles

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Lukas Owens, Kemal Caglar Gogebakan, Usha Menon, Roman Gulati, Noel S. Weiss, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2023) 32 (6): 741–743.

https://doi.org/10.1158/1055-9965.EPI-22-1307

Published: 01 June 2023

View articletitled, Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Journal Articles

Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States

Theresa P. Devasia, Angela B. Mariotto, Yaw A. Nyame, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2023) 32 (5): 659–665.

https://doi.org/10.1158/1055-9965.EPI-22-1038

Published: 01 May 2023

View articletitled, Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States

Includes: Supplementary data

Journal Articles

Abstract B100: The role of place in racial disparities in prostate cancer treatment

Noah Hammarlund, Jenney Lee, Erika Wolff, Sarah Holt, Ruth Etzioni, John Gore, Yaw A. Nyame

Cancer Epidemiol Biomarkers Prev (2023) 32 (1_Supplement): B100.

https://doi.org/10.1158/1538-7755.DISP22-B100

Published: 01 January 2023

View articletitled, Abstract B100: The role of place in racial disparities in prostate cancer treatment

Journal Articles

Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests

Lukas Owens, Roman Gulati, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1298–1304.

https://doi.org/10.1158/1055-9965.EPI-22-0024

Published: 01 July 2022

View articletitled, Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests

Journal Articles

Cancer Modeling as Learning Experience

Ruth Etzioni, Jane Lange

Cancer Epidemiol Biomarkers Prev (2022) 31 (4): 702–703.

https://doi.org/10.1158/1055-9965.EPI-21-1409

Published: 01 April 2022

View articletitled, Cancer Modeling as Learning Experience

Journal Articles

A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing

Boshen Jiao, Roman Gulati, Hormuzd A. Katki, Philip E. Castle, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 38–44.

https://doi.org/10.1158/1055-9965.EPI-21-0380

Published: 01 January 2022

View articletitled, A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing

Includes: Supplementary data

Journal Articles

Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach

Kemal Caglar Gogebakan, Elizabeth G. Berry, Alan C. Geller, Kemal Sonmez, Sancy A. Leachman, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2020) 29 (12): 2599–2607.

https://doi.org/10.1158/1055-9965.EPI-20-0881

Published: 01 December 2020

View articletitled, Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach

Includes: Supplementary data

Journal Articles

Abstract PO-211: Racial disparities in the quality of surgical care among Medicare beneficiaries with prostate cancer

Yaw A. Nyame, Sarah K. Holt, Ruth Etzioni, John L. Gore

Cancer Epidemiol Biomarkers Prev (2020) 29 (12_Supplement): PO-211.

https://doi.org/10.1158/1538-7755.DISP20-PO-211

Published: 30 November 2020

View articletitled, Abstract PO-211: Racial disparities in the quality of surgical care among Medicare beneficiaries with prostate cancer

Journal Articles

Abstract A09: Predicting recurrence or second breast cancer using linked claims and cancer registry data with limited gold-standard information: A gradient-boosting approach

Teresa A'mar, Daniel Markowitz, Jessica Chubak, David Beatty, Catherine Fedorenko, Christopher Li, Kathi Malone, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2020) 29 (9_Supplement): A09.

https://doi.org/10.1158/1538-7755.MODPOP19-A09

Published: 01 September 2020

View articletitled, Abstract A09: Predicting recurrence or second breast cancer using linked claims and cancer registry data with limited gold-standard information: A gradient-boosting approach

Journal Articles

Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer

Angela B. Mariotto, Zhaohui Zou, Fanni Zhang, Nadia Howlader, Allison W. Kurian, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2018) 27 (11): 1332–1341.

https://doi.org/10.1158/1055-9965.EPI-17-1129

Published: 01 November 2018

View articletitled, Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer

Includes: Supplementary data

Journal Articles

Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

Angela B. Mariotto, Ruth Etzioni, Marc Hurlbert, Lynne Penberthy, Musa Mayer

Cancer Epidemiol Biomarkers Prev (2017) 26 (6): 809–815.

https://doi.org/10.1158/1055-9965.EPI-16-0889

Published: 31 May 2017

View articletitled, Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

Includes: Supplementary data

Journal Articles

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Roman Gulati, Heather H. Cheng, Paul H. Lange, Peter S. Nelson, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2017) 26 (2): 222–227.

https://doi.org/10.1158/1055-9965.EPI-16-0434

Published: 05 February 2017

View articletitled, Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Journal Articles

Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer

Jeanette K. Birnbaum, Ziding Feng, Roman Gulati, Jing Fan, Yair Lotan, John T. Wei, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2015) 24 (4): 677–682.

https://doi.org/10.1158/1055-9965.EPI-14-1224

Published: 31 March 2015

View articletitled, Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer

Includes: Supplementary data

Journal Articles

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Roman Gulati, Elisabeth M. Wever, Alex Tsodikov, David F. Penson, Lurdes Y.T. Inoue, Jeffrey Katcher, Shih-Yuan Lee, Eveline A.M. Heijnsdijk, Gerrit Draisma, Harry J. de Koning, Ruth Etzioni

Cancer Epidemiol Biomarkers Prev (2011) 20 (5): 740–750.

https://doi.org/10.1158/1055-9965.EPI-10-0718

Published: 04 May 2011

View articletitled, What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Includes: Supplementary data

Journal Articles

Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006

Stacey A. Fedewa, Ruth Etzioni, W. Dana Flanders, Ahmedin Jemal, Elizabeth M. Ward

Cancer Epidemiol Biomarkers Prev (2010) 19 (10): 2437–2444.

https://doi.org/10.1158/1055-9965.EPI-10-0299

Published: 06 October 2010

View articletitled, Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Sensitivity Measures in Studies of Cancer Early Detection Biomarkers

Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study

Abstract B084: Multi-Stakeholder Engagement to Create Equity in Prostate Cancer Outcomes through Identifying Community Priorities in Early Detection Research

Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Isolating the Drivers of Racial Inequities in Prostate Cancer Treatment

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Estimating the Number of Men Living with Metastatic Prostate Cancer in the United States

Abstract B100: The role of place in racial disparities in prostate cancer treatment

Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests

Cancer Modeling as Learning Experience

A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing

Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach

Abstract PO-211: Racial disparities in the quality of surgical care among Medicare beneficiaries with prostate cancer

Abstract A09: Predicting recurrence or second breast cancer using linked claims and cancer registry data with limited gold-standard information: A gradient-boosting approach

Can We Use Survival Data from Cancer Registries to Learn about Disease Recurrence? The Case of Breast Cancer

Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only